On September 30, 2025, Indian stock markets ended almost flat after a volatile F&O expiry-led session. The Sensex slipped 97.32 points, or 0.12%, to close at 80,267.62, while the Nifty 50 fell 23.80 points, or 0.10%, to settle at 24,611.10. This marked the eighth straight day of losses, as persistent foreign investor selling weighed on sentiment.
Investors remain cautious ahead of the RBI’s Monetary Policy Committee (MPC) decision due tomorrow, where rates are expected to remain unchanged. Meanwhile, sectoral performance was mixed—PSU Banks, Metals, and Auto gained between 0.4% and 2%, while Media and Realty indices underperformed, each down around 1%.
Against this backdrop, here are six stocks that are worth tracking in today’s trading session.
Sundaram Finance Ltd. [NSE: SUNDARMFIN]
Sundaram Finance continues to deliver steady performance as one of India’s leading NBFCs in the vehicle finance and retail lending space. The company has strong fundamentals with a healthy P/E ratio of 25.07 and consistent dividend payouts, reflected in its dividend yield of 0.80%.
The stock has been trading close to its support levels, making it attractive for long-term investors seeking exposure to the auto financing segment. Its stable balance sheet and focus on rural and SME lending could help sustain earnings momentum, especially if the RBI maintains its current policy stance.
| Closing Price (as of Sep 30, 2025) | ₹4,411.50 |
| Average Trading Volume | 108.89K |
| Company Type | Mid Cap |
| Market Cap | ₹48.13KCr |
| P/E Ratio | 25.07 |
| Dividend Yield | 0.80% |
| Beta | 1.02 |
ZF Commercial Vehicle Control Systems India Ltd. [NSE: ZFCVINDIA]
ZF CVCS India recently crossed its 200-day moving average (200 DMA) at ₹12,558, closing at ₹12,905, signalling a positive technical breakout. The company, a key player in commercial vehicle braking and control systems, stands to benefit from India’s rising CV sales and infrastructure-led demand growth.
Its strong P/E of 50.59 reflects premium valuations for its niche positioning. Technical indicators suggest potential upside momentum, making it a stock to watch in the auto components sector.
| Closing Price (as of Sep 30, 2025) | ₹12,905.00 |
| Average Trading Volume | 9.97K |
| Company Type | Mid Cap |
| Market Cap | ₹24.47KCr |
| P/E Ratio | 50.59 |
| Dividend Yield | 0.15% |
| Beta | 0.55 |
Nuvama Wealth Management Ltd. [NSE: NUVAMA]
Analysts see strong upside potential in Nuvama Wealth Management, with estimates suggesting a possible target of around ₹10,000 per share — indicating over 60% upside from current levels. The stock has been consolidating around the ₹6,000 zone and is now showing strength with strong volumes and positive momentum.
Nuvama reported robust growth in Q1 FY25, with sales up 18% YoY to ₹1,123 crore and net profit up 19% to ₹264 crore. Its diversified revenue streams across wealth management, asset servicing, and investment banking mitigate risks from client concentration.
With strong technical support at ₹5,800 and growing fundamentals, Nuvama remains a high-conviction buy for both short-term traders and long-term investors.
| Closing Price (as of Sep 30, 2025) | ₹6,305.00 |
| Average Trading Volume | 130.83K |
| Company Type | Mid Cap |
| Market Cap | ₹23.14KCr |
| P/E Ratio | 23.05 |
| Dividend Yield | 2.06% |
| Beta | 1.47 |
Alembic Pharmaceuticals Ltd. [NSE: APLLTD]
Alembic Pharma, along with other pharma majors, rebounded recently after clarification that the new US drug tariffs would apply only to branded and patented drugs, not generic medicines. Since generics account for the bulk of India’s pharma exports, Alembic’s business impact remains limited.
The stock corrected last week but has found renewed strength. With a P/E ratio of 29.35 and a dividend yield of 1.22%, Alembic remains a solid defensive pick amid global trade uncertainties. Analysts expect Indian pharma companies to benefit from stability in generic exports and long-term diversification into biosimilars.
| Closing Price (as of Sep 30, 2025) | ₹901.35 |
| Average Trading Volume | 105.75K |
| Company Type | Mid Cap |
| Market Cap | ₹17.71KCr |
| P/E Ratio | 29.35 |
| Dividend Yield | 1.22% |
| Beta | 0.51 |
Grindwell Norton Ltd. [NSE: GRINDWELL]
Grindwell Norton, a leader in abrasives and industrial materials, maintains a strong balance sheet with net cash of ₹7.95 billion, far exceeding its debt levels. Its short-term liquidity remains robust, with more liquid assets than total liabilities, reducing financial risk.
While EBIT declined 6.4% over the past year, consistent free cash flow (59% of EBIT) supports the company’s ability to manage debt comfortably. With India’s manufacturing growth and industrial expansion, Grindwell Norton is well-positioned for long-term growth despite near-term earnings pressure.
| Closing Price (as of Sep 30, 2025) | ₹1,588.20 |
| Average Trading Volume | 63.82K |
| Company Type | Mid Cap |
| Market Cap | ₹17.88KCr |
| P/E Ratio | 48.32 |
| Dividend Yield | 1.05% |
| Beta | 0.91 |
Wipro Ltd. [NSE: WIPRO]
Wipro remains a steady large-cap IT player, with a focus on digital, cloud, and AI-driven services. The company’s stock trades at a reasonable P/E of 18.69 with a strong dividend yield of 3.96%, offering attractive income potential.
Despite near-term margin pressures across the IT sector, Wipro’s diversified global presence and consistent cash generation make it a relatively defensive pick in volatile market conditions. Its stable fundamentals and high dividend payouts make it suitable for investors looking at steady returns rather than aggressive growth.
| Closing Price (as of Sep 30, 2025) | ₹239.37 |
| Average Trading Volume | 8.67M |
| Company Type | Large Cap |
| Market Cap | ₹2.51LCr |
| P/E Ratio | 18.69 |
| Dividend Yield | 3.96% |
| Beta | 1.08 |
Conclusion
The market remains cautious ahead of the RBI policy decision and global macro headwinds. However, selective opportunities exist across different sectors like Auto, Finance, Pharma, Financial Services, Industrial and IT sector.
Sectorial Bifurcation:
- Auto & Finance: Sundaram Finance, ZF CVCS India
- Financial Services: Nuvama Wealth Management
- Pharma: Alembic Pharmaceuticals
- Industrials: Grindwell Norton
- IT: Wipro
Diversification across these plays offers a blend of defensive stability, technical strength, and sector-specific growth potential.
Stock trading does not offer guaranteed returns. To make informed trading decisions, consider a company’s fundamentals, including revenue growth and earnings stability, as well as sector performance and market trends. Look for stocks with high liquidity and volatility that match your trading style (day trading or swing trading). Focus on strategies like technical analysis (chart patterns, indicators like MACD and RSI) and fundamental analysis (earnings reports and news catalysts).
Having a proper risk management strategy is equally important to minimise losses. Use stop-loss orders and position sizing to protect your capital. Develop a trading plan with clear entry and exit criteria based on your risk tolerance.
Just starting out with investing? Begin your stock market journey by opening a Demat Account with Torus Digital today.
